David Longo is the visionary Founder and CEO of Ordaos Bio, architecting the future of drug discovery. He leads a pioneering team using a sophisticated AI Design Engine to create bespoke mini-proteins, unlocking new possibilities for treating complex diseases. This platform represents a leap forward, rapidly iterating designs based on real-world lab feedback to target ailments previously beyond reach. David's unique strength lies at the intersection of deep tech and life sciences, holding advanced credentials in Biotechnology (Harvard), AI/ML (Stanford), and Innovation (MIT), alongside a foundation in Computational Mathematics (RIT). This potent combination fuels his unconventional approach. Before Ordaos, David built successful companies, including an award-winning music venture, demonstrating a consistent ability to identify and scale innovation. A recognized leader and relentless learner, David embodies the multidisciplinary drive shaping tomorrow's breakthroughs in medicine. He is also an avid triathlete and biohacker.